Yorghos Apostolopoulos| Epidemiology | Innovative Research Award

Posted on by Global HRM Awards

Innovative Research Award

Yorghos Apostolopoulos
Affiliation Independent Research
Country Greece
Scopus ID 57203223915
Documents 45
Citations 1,313
h-index 21
Subject Area  Epidemiology
Event Global HRM Awards

Yorghos Apostolopoulos
Independent Research,Greece

Yorghos Apostolopoulos is an internationally recognized population health scientist, epidemiologist, and interdisciplinary researcher whose scholarly contributions span occupational health, tourism studies, migrant worker health, transportation safety, and working-life exposome research. His work integrates epidemiology, systems science, social determinants of health, and public health policy to address complex global health challenges.[1]

His academic profile demonstrates substantial contributions to healthcare disparities research, occupational epidemiology, transportation health systems, hospitality workforce health, and integrative population health frameworks with global interdisciplinary impact.[2]

Abstract

Yorghos Apostolopoulos has contributed extensively to interdisciplinary population health and epidemiological research involving occupational health disparities, transportation safety, tourism crises, migrant worker health, and hospitality workforce wellbeing. His scholarly investigations integrate systems science, social epidemiology, and working-life exposome frameworks to improve public health research, policy development, and workforce sustainability strategies.[3]

Keywords

Population Health; Epidemiology; Occupational Health; Working-Life Exposome; Public Health; Transportation Safety; Tourism Research; Migrant Worker Health; Healthcare Disparities; Hospitality Workforce.

Introduction

Population health and epidemiological research play critical roles in addressing complex societal health challenges associated with occupational exposures, migration, transportation systems, tourism dynamics, and workplace wellbeing. Interdisciplinary public health research contributes to evidence-based policymaking, occupational safety improvements, and healthcare equity initiatives worldwide.[4]

Yorghos Apostolopoulos has developed scholarly frameworks that connect epidemiology, systems science, workforce health, tourism research, and social determinants of health to advance understanding of occupational and population health outcomes across multiple sectors.[5]

Research Profile

Yorghos Apostolopoulos serves as Executive Director and Senior Population Health Scientist at Prolepsis: Partners in Prevention, Inc., United States. His research portfolio encompasses occupational epidemiology, public health systems, tourism crises, commercial transportation health, migrant labor health disparities, and integrative exposome science.[6]

His Scopus profile records 45 indexed documents with more than 1,300 citations and an h-index of 21, while his Google Scholar metrics exceed 7,900 citations with an h-index of 47, reflecting broad scholarly influence across interdisciplinary public health domains.[7]

Research Contributions

Apostolopoulos has contributed significantly to occupational health research involving long-haul truck drivers, including investigations into sleep quality, cardiovascular disease risks, mental health disorders, worksite-induced morbidities, and transportation safety outcomes. His tourism and hospitality research explores terrorism impacts on tourism systems, COVID-19 effects on hospitality workers, public health crises within tourism industries, and sociological aspects of tourism and migration.

More recent scholarly work has focused on the working-life exposome framework, systems-AI methodologies, and integrative population health paradigms designed to improve epidemiological research and policy innovation within occupational and transportation health systems

Publications

  • Tourism in Crisis: Managing the Effects of Terrorism, Journal of Travel Research, 1999.
    [5]
  • The Hospitality Industry in the Face of the COVID-19 Pandemic: Current Topics and Research Methods, International Journal of Environmental Research and Public Health, 2020.
    [6]
  • Health Survey of US Long-Haul Truck Drivers: Work Environment, Physical Health, and Healthcare Access, Work, 2013.
    [7]
  • The Indispensable Whole of Work and Population Health: How the Working Life Exposome Can Advance Empirical Research, Policy, and Action, Scandinavian Journal of Work Environment and Health, 2024.
  • Occupational Stressors and the Mental Health of Truckers, Issues in Mental Health Nursing, 2010.

Research Impact

The scholarly contributions of Yorghos Apostolopoulos have influenced interdisciplinary public health research, occupational safety policies, transportation health studies, tourism resilience strategies, and workforce wellbeing initiatives. His publications are widely cited across epidemiology, healthcare, occupational health, and tourism research disciplines.

Award Suitability

Yorghos Apostolopoulos demonstrates sustained international scholarly impact through interdisciplinary research excellence, highly cited publications, innovative epidemiological frameworks, and contributions to occupational and population health sciences. His research profile aligns strongly with award recognition criteria emphasizing public health innovation, global research impact, and interdisciplinary scientific advancement.

Conclusion

The academic and research contributions of Yorghos Apostolopoulos reflect substantial leadership in population health, epidemiology, occupational safety, transportation health systems, and tourism-related public health research. His interdisciplinary scholarship continues to contribute to evidence-based public health strategies and global healthcare improvement initiatives.

References

  1. Elsevier Scopus. (2026). Author profile of Yorghos Apostolopoulos, Scopus ID 57203223915.
    https://www.scopus.com/authid/detail.uri?authorId=57203223915
  2. Google Scholar. (2026). Academic citation metrics and publication profile of Yorghos Apostolopoulos.
    https://scholar.google.com/citations?user=RKQ-hiUAAAAJ&hl=en
  3. Apostolopoulos, Y., et al. (2013). Health survey of US long-haul truck drivers: Work environment, physical health, and healthcare access.
    https://doi.org/10.3233/WOR-131734
  4. Davahli, M.R., Karwowski, W., Sonmez, S., Apostolopoulos, Y. (2020). The hospitality industry in the face of the COVID-19 pandemic: Current topics and research methods.
    https://doi.org/10.3390/ijerph17207366
  5. .Sönmez, S.F., Apostolopoulos, Y., Tarlow, P. (1999). Tourism in crisis: Managing the effects of terrorism.
    Journal of Travel Research.
    https://doi.org/10.1177/004728759903800104
  6. International Journal of Environmental Research and Public Health. (2020). The hospitality industry in the face of the COVID-19 pandemic: Current topics and research methods.
    https://doi.org/10.3390/ijerph17207366
  7. Apostolopoulos, Y., et al. (2013). Health survey of US long-haul truck drivers: Work environment, physical health, and healthcare access.
    Work.
    https://doi.org/10.3233/WOR-131734

Andrea Raynak |  Healthcare Research | Innovative Research Award

Posted on by Global HRM Awards

Innovative Research Award

Andrea Raynak
Affiliation Thunder Bay Regional Health Sciences Centre
Country Canada
Scopus ID 57203260815
Documents 11
Citations 83
h-index 4
Subject Area  Healthcare Research
Event Global HRM Awards

Andrea Raynak
Thunder Bay Regional Health Sciences Centre, Canada

Andrea Raynak is a Canadian nursing researcher affiliated with Thunder Bay Regional Health Sciences Centre whose academic contributions focus on nursing practice, substance use in healthcare environments, vascular access education, healthcare workforce sustainability, and transition-to-practice nursing research. Her scholarly profile demonstrates interdisciplinary contributions to healthcare quality improvement, nursing retention strategies, and evidence-based clinical education.[1]

Her work combines nursing science, healthcare systems research, public health methodologies, and clinical practice evaluation to support patient-centered care, healthcare workforce resilience, and nursing education advancement across Canada.[2]

Abstract

Andrea Raynak has contributed to healthcare and nursing research through studies involving nursing workforce sustainability, patient care quality, vascular access education, transition-to-practice frameworks, and substance use care within hospital settings. Her research supports evidence-based nursing interventions and healthcare improvement strategies within clinical and academic environments.[3]

Keywords

Nursing Research; Public Health; Clinical Nursing; Healthcare Workforce; Substance Use Care; Nursing Education; Patient Care Quality; Vascular Access; Healthcare Systems; Transition to Practice.

Introduction

Modern healthcare systems increasingly depend on evidence-based nursing practices, workforce sustainability, patient-centered care models, and interdisciplinary healthcare collaboration. Nursing research contributes significantly to improving patient outcomes, clinical education, healthcare access, and healthcare delivery systems.[4]

Andrea Raynak’s scholarly activities contribute to this field through research examining nursing attitudes, healthcare workforce retention, intravenous drug use management in hospital settings, and transition-to-practice initiatives for nursing professionals.[5]

Research Profile

Andrea Raynak is affiliated with Thunder Bay Regional Health Sciences Centre and has academic experience in nursing, public health, and healthcare systems research. Her educational background includes a Bachelor of Science in Nursing, a Master of Public Health with Nursing specialization, and doctoral studies in Health Sciences.[6]

Her Scopus-indexed publications and collaborative research activities reflect engagement in nursing science, healthcare workforce sustainability, patient safety, vascular access education, and substance use healthcare research.

Research Contributions

Andrea Raynak has contributed to research examining nurses’ attitudes toward patients who use substances in hospital settings through systematic and scoping review methodologies. Her studies support evidence-informed healthcare interventions and improved patient-centered clinical care approaches

Her research also addresses retention and attrition challenges in rural and northern healthcare environments, emphasizing sustainable workforce strategies and improved nursing retention within Canadian healthcare systems.

Additional scholarly contributions include nursing transition-to-practice models, vascular access education, intravenous drug use management in clinical environments, and evidence-based nursing education initiatives.

Publications

  • Examining Nurses’ Attitudes Toward Patients Who Use Substances in the Hospital Setting: A Scoping Review, International Journal of Nursing Studies Advances, 2026.
  • Stemming the Tide: Tackling Retention and Attrition Challenges in Rural and Northern Healthcare to Sustain Canada’s Nursing Workforce, Journal of Advanced Nursing, 2026.
  • Optimizing Academic-Practice Partnerships to Promote Transition to Nursing Practice, Canadian Journal of Nursing Research, 2026.
  • Intravenous Drug Use in the Hospital Setting, Journal of Addictions Nursing, 2024.
  • Nurses’ Knowledge on Routine Care and Maintenance of Adult Vascular Access Devices: A Scoping Review, Journal of Clinical Nursing, 2020.

Research Impact

The research activities of Andrea Raynak contribute to nursing workforce development, healthcare quality improvement, evidence-based clinical education, and patient-centered healthcare systems. Her scholarly work supports sustainable healthcare delivery and strengthens nursing practice standards within clinical environments.

Award Suitability

Andrea Raynak demonstrates strong scholarly engagement in healthcare and nursing sciences through peer-reviewed publications, interdisciplinary collaborations, and research focused on healthcare improvement and nursing sustainability. Her contributions align with recognition criteria emphasizing innovation, healthcare impact, and evidence-based nursing advancement.

Conclusion

Andrea Raynak’s research profile reflects meaningful contributions to nursing science, public health, healthcare systems, and clinical education. Her work supports ongoing advancements in patient-centered care, healthcare workforce resilience, and evidence-based nursing practices within modern healthcare environments.

References

  1. Elsevier Scopus. (2026). Author profile of Andrea Raynak, Scopus ID 57203260815.
    https://www.scopus.com/authid/detail.uri?authorId=57203260815
  2. ORCID. (2026). Andrea Raynak researcher profile and academic activities.
    https://orcid.org/0000-0003-0653-3185
  3. International Journal of Nursing Studies Advances. (2026). Examining nurses’ attitudes toward patients who use substances in the hospital setting: A scoping review.
    https://doi.org/10.1016/j.ijnsa.2026.100513
  4. Raynak, A., et al. (2026). Examining nurses’ attitudes toward patients who use substances in the hospital setting: A scoping review.
    https://doi.org/10.1016/j.ijnsa.2026.100513
  5. Raynak, A., et al. (2026). Stemming the Tide: Tackling Retention and Attrition Challenges in Rural and Northern Healthcare to Sustain Canada’s Nursing Workforce.
    https://doi.org/10.1111/jan.70255
  6. Canadian Journal of Nursing Research. (2026). Optimizing academic-practice partnerships to promote transition to nursing practice.
    https://doi.org/10.1177/08445621251366583

Changgui Li | Gout | Innovative Research Award

Posted on by Global HRM Awards

Innovative Research Award

Changgui Li
Affiliation Xiamen University
Country China
Scopus ID 35313424500
Documents 100+
Citations 29
h-index 3
Subject Area  Gout
Event Global HRM Awards

Changgui Li
Xiamen University,  China

Changgui Li is a researcher recognized for scholarly contributions in rheumatology, gout research, hyperuricemia, metabolomics, inflammatory disease mechanisms, renal complications, and translational medicine. His publication record demonstrates active participation in collaborative scientific investigations related to gout pathogenesis, metabolic disorders, therapeutic interventions, biomarker discovery, and genomic analyses.[1]

His research activities include studies involving metabolomics, genome-wide association analyses, inflammatory biomarkers, clinical cohort investigations, and therapeutic evaluations associated with gout and metabolic diseases.[2]

Abstract

Changgui Li has contributed to the advancement of rheumatology and metabolic disease research through investigations involving gout pathophysiology, hyperuricemia, metabolomics, inflammatory biomarkers, renal complications, microbiota regulation, and therapeutic response evaluation. His studies integrate clinical investigations, genomic analyses, metabolomic profiling, machine learning approaches, and translational medicine methodologies for improved understanding of gout-related disorders.[3]

Keywords

Rheumatology; Gout; Hyperuricemia; Metabolomics; Biomarkers; Genome-Wide Association Studies; Inflammatory Diseases; Renal Function; Precision Medicine; Clinical Research.

Introduction

Gout and hyperuricemia represent significant public health concerns associated with inflammatory responses, renal dysfunction, metabolic abnormalities, and chronic disease progression. Contemporary rheumatology research increasingly focuses on biomarker discovery, metabolic profiling, precision medicine, and therapeutic optimization for improved patient outcomes.[4]

Research Profile

The research profile of Changgui Li includes scholarly publications in rheumatology, inflammatory diseases, metabolomics, endocrinology, nephrology, and clinical medicine journals. His work has appeared in Arthritis and Rheumatology, Arthritis Research and Therapy, Rheumatology, Frontiers in Endocrinology, Annals of Medicine, Chemosphere, and other indexed scientific journals.[6]

Research Contributions

Changgui Li has contributed to studies investigating metabolic biomarkers associated with gout flares, obesity-related disease mechanisms, renal urate underexcretion, inflammatory responses, and microbiota-mediated metabolic regulation.[5]

His collaborative investigations additionally include genome-wide association analyses involving large international cohorts, machine learning-assisted predictive models, therapeutic comparative effectiveness studies, and epidemiological analyses examining disease prevalence and clinical outcomes.

Publications

  • Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares, Arthritis and Rheumatology, 2023.
  • Novel genetic loci in adolescent-onset gout derived from whole genome sequencing of a Chinese cohort, medRxiv, 2023.
  • Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout, Rheumatology, 2023.
  • A machine learning-assisted model for renal urate underexcretion with genetic and clinical variables among Chinese men with gout, Arthritis Research and Therapy, 2022.
  • Kidney and plasma metabolomics provide insights into the molecular mechanisms of urate nephropathy in a mouse model of hyperuricemia, Biochimica et Biophysica Acta – Molecular Basis of Disease, 2022.
  • Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion, Arthritis and Rheumatology, 2022.

Research Impact

The research contributions of Changgui Li support advancements in rheumatology, metabolic disease management, inflammatory biomarker discovery, metabolomic profiling, microbiota regulation, and precision medicine approaches. His studies contribute to improved understanding of gout progression, renal complications, metabolic dysfunction, and therapeutic response mechanisms

Award Suitability

Changgui Li demonstrates a sustained research profile in rheumatology and metabolic medicine through publication activity, international collaboration, translational investigations, and interdisciplinary scientific contributions. His work aligns with research excellence recognition criteria emphasizing scientific quality, innovation, clinical relevance, and evidence-based medical advancement.

Conclusion

The scholarly activities of Changgui Li contribute to the advancement of gout research, metabolomics, inflammatory disease understanding, and translational rheumatology science. His research demonstrates ongoing engagement in multidisciplinary investigations focused on improving clinical understanding and therapeutic approaches for metabolic and inflammatory disorders.

References

  1. ORCID. (2026). Changgui Li ORCID profile and scholarly activities.
    https://orcid.org/0000-0002-4622-3731
  2. Elsevier Scopus. (2026). Indexed research publications and collaborative studies associated with Changgui Li.
    https://www.scopus.com/authid/detail.uri?authorId=57252600000
  3. Arthritis and Rheumatology. (2023). Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
    https://doi.org/10.1002/art.42635
  4. Annals of Medicine. (2022). Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies.
    https://doi.org/10.1080/07853890.2022.2083670
  5. Acta Pharmaceutica Sinica B. (2023). Pathophysiology of obesity and its associated diseases.
    https://doi.org/10.1016/j.apsb.2023.01.012
  6. Rheumatology (United Kingdom). (2023). Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout.
    https://doi.org/10.1093/rheumatology/keac507